Corona Remedies Limited IPO
Exchange: NSE & BSE · Face Value: ₹10
Current GMP
Est. Listing
₹1406
IPO Details & Issue Structure
Corona Remedies Limited IPO Timetable
Lot Size & Minimum Investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | ₹14,868 |
| Retail (Max) | 13 | 182 | ₹1,93,284 |
Registrar & Allotment
Bigshare Services Private Limited
https://ipo.bigshareonline.com/IPO_Status.htmlCheck Allotment StatusAbout Corona Remedies Limited IPO & Grey Market Premium
Everything you need to know before applying for Corona Remedies Limited IPO.
IPO Grey Market Premium (GMP) represents the unofficial premium at which Initial Public Offering (IPO) shares are traded among investors before they officially list on the stock exchanges (NSE/BSE). Traders closely track real-time GMP fluctuations to evaluate market sentiment.
What Does Positive GMP Indicate?
A strong positive grey market premium suggests solid buyer demand and market interest, hinting that the stock could open with healthy listing day gains above its issue price.
How Estimated Listing Price is Calculated
Estimated Listing Price = Upper Price Band + Current GMP (₹). For instance, if an issue is priced at ₹100 with ₹30 GMP, the estimated listing price is ₹130 (+30%).
Key Factors Affecting Live IPO GMP Today
- Subscription Numbers: Heavy bidding observed by QIB (Qualified Institutional Buyers) and NII (Non-Institutional Investors) directly propels the grey market price upward.
- Broader Market Sentiments: Nifty and Sensex trends have a direct bearing on pre-listing demand.
- Allotment & Fundamentals: Fairly priced issues with steady buyer demand post-allotment maintain stable grey market demand compared to overvalued issues.
Corona Remedies Limited IPO has a price band of ₹1008 to ₹1062 per equity share. The current live Grey Market Premium (GMP) is ₹344, which suggests an estimated listing price of ₹1406 (32.4% premium).
To evaluate institutional demand and retail bid counts across BSE and NSE, investors can inspect the live live ipo subscription feed before finalizing their bidding strategy.